CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement
PR Newswire•23/09/2026•07:00 ET
0
CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire
PRINCETON, N.J., Sept. 23, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that it has regained compliance with the Nasdaq Stock Market's minimum bid price requirement of $1.00 per share.
Get started
Create a free account to read the full story and Whiz Insights.